Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines

被引:283
作者
Pukrop, T
Klemm, F
Hagemann, T
Gradl, D
Schulz, M
Siemes, S
Trümper, L
Binder, C [1 ]
机构
[1] Univ Gottingen, Dept Haematol Oncol, D-37099 Gottingen, Germany
[2] Canc Res UK, Translat Oncol Lab, Queen Marys Sch Med & Dent, London EC1M 6BQ, England
[3] Univ Karlsruhe, Inst Zool, D-76128 Karlsruhe, Germany
基金
英国医学研究理事会;
关键词
tumor microenvironment; TNF-alpha; matrix metalloproteases;
D O I
10.1073/pnas.0509703103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Interactions between neoplastic and stromal cells contribute to tumor progression. Wnt genes, involved in cell migration and often deregulated in cancers, are attractive candidates to regulate these effects. We have recently shown that coculture of breast cancer cells with macrophages enhances invasiveness via matrix metal loproteases and TNF-alpha. Here we demonstrate that coculture of MCF-7 cells and macrophages leads to up-regulation of Writ 5a in the latter. This was accompanied by activation of AP-1/c-Jun in MCF-7. Recombinant Writ 5a mimicked the coculture effect. Writ 5a was also detectable in tumor-associated macrophages in primary breast cancers. Experiments with agonists and antagonists of Writ signaling revealed that a functional canonical pathway in the tumor cells was a necessary prerequisite; however, noncanonical signaling via Writ 5a and the Jun-N-terminal kinase pathway was critical for invasiveness. It was also responsible for induction of matrix metalloprotease-7, known to release TNF-alpha. All these effects could be antagonized by dickkopf-1. Our results indicate that Wnt 5a is essential for macrophage-induced invasiveness, because it regulates tumor cell migration as well as proteolytic activity of the macrophages. The function of Writ 5a as either a suppressor or promoter of malignant progression seems to be modulated by intercellular interactions. Writ 5a detection in tumor-associated macrophages in breast cancer biopsies supports the assumption that similar events play a role in vivo.
引用
收藏
页码:5454 / 5459
页数:6
相关论文
共 50 条
[1]   Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow [J].
Bafico, A ;
Liu, GZ ;
Yaniv, A ;
Gazit, A ;
Aaronson, SA .
NATURE CELL BIOLOGY, 2001, 3 (07) :683-686
[2]   Smoldering and polarized inflammation in the initiation and promotion of malignant disease [J].
Balkwill, F ;
Charles, KA ;
Mantovani, A .
CANCER CELL, 2005, 7 (03) :211-217
[3]   Functional interaction of beta-catenin with the transcription factor LEF-1 [J].
Behrens, J ;
vonKries, JP ;
Kuhl, M ;
Bruhn, L ;
Wedlich, D ;
Grosschedl, R ;
Birchmeier, W .
NATURE, 1996, 382 (6592) :638-642
[4]   Molecular classification of cutaneous malignant melanoma by gene expression profiling [J].
Bittner, M ;
Meitzer, P ;
Chen, Y ;
Jiang, Y ;
Seftor, E ;
Hendrix, M ;
Radmacher, M ;
Simon, R ;
Yakhini, Z ;
Ben-Dor, A ;
Sampas, N ;
Dougherty, E ;
Wang, E ;
Marincola, F ;
Gooden, C ;
Lueders, J ;
Glatfelter, A ;
Pollock, P ;
Carpten, J ;
Gillanders, E ;
Leja, D ;
Dietrich, K ;
Beaudry, C ;
Berens, M ;
Alberts, D ;
Sondak, V ;
Hayward, N ;
Trent, J .
NATURE, 2000, 406 (6795) :536-540
[5]   Low expression of Wnt-5a gene is associated with high-risk neuroblastoma [J].
Blanc, E ;
Le Roux, G ;
Bénard, J ;
Raguénez, G .
ONCOGENE, 2005, 24 (07) :1277-1283
[6]   Nuclear overexpression of the oncoprotein β-catenin in colorectal cancer is localized predominantly at the invasion front [J].
Brabletz, T ;
Jung, A ;
Hermann, K ;
Gunther, K ;
Hohenberger, W ;
Kirchner, T .
PATHOLOGY RESEARCH AND PRACTICE, 1998, 194 (10) :701-704
[7]   The DIX domain targets dishevelled to actin stress fibres and vesicular membranes [J].
Capelluto, DGS ;
Kutateladze, TG ;
Habas, R ;
Finkielstein, CV ;
He, X ;
Overduin, M .
NATURE, 2002, 419 (6908) :726-729
[8]  
Dejmek J, 2005, CLIN CANCER RES, V11, P520
[9]  
Dennis S, 1999, J CELL SCI, V112, P3815
[10]   The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer [J].
Gonzálex-Sancho, JM ;
Aguilera, O ;
García, JM ;
Pendás-Franco, N ;
Peña, C ;
Cal, S ;
de Herreros, AG ;
Bonilla, F ;
Muñoz, A .
ONCOGENE, 2005, 24 (06) :1098-1103